Fundraising FoxNanil Therapeutics Inc.
1 known investors
Find your way into Nanil Therapeutics Inc.
161 people in our graph can introduce you to the Nanil Therapeutics Inc. team.
Sign up to see every warm intro you have to Nanil Therapeutics Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nanil Therapeutics Inc. team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nanil Therapeutics develops AI-native discovery platforms for CNS-targeting therapeutic modalities, focusing on RNA-based approaches for neurodegenerative diseases like tauopathies and Alzheimer's. The company integrates quantum computing, generative AI, and molecular modeling to design and optimize mRNA therapeutics and identify blood-brain barrier-penetrant biologics.
Founders & leadership
BR
Bini Raj SkyPharmacology LeadBini Raj Sky holds a PhD in Pharmacology from the University of Virginia and has held postdoctoral and research positions in neuropharmacology at Harvard University and the University of California, San Francisco. He serves as Scientific Director at Nanil Therapeutics, which develops AI-powered discovery platforms for CNS-targeting RNA-based therapeutics.
Investors · 1
Frequently asked questions
- What does Nanil Therapeutics Inc. do?
- Nanil Therapeutics develops AI-native discovery platforms for CNS-targeting therapeutic modalities, focusing on RNA-based approaches for neurodegenerative diseases like tauopathies and Alzheimer's. The company integrates quantum computing, generative AI, and molecular modeling to design and optimize mRNA therapeutics and identify blood-brain barrier-penetrant biologics.
- Who are Nanil Therapeutics Inc.'s investors?
- Nanil Therapeutics Inc.'s investors include CABHI Ventures.